中国中医药现代远程教育
中國中醫藥現代遠程教育
중국중의약현대원정교육
CHINESE MEDICINE MODERN DISTANCE EDUCATION OF CHINA
2014年
18期
11-13
,共3页
李华南%吴谋建%刘峰%顾兵%张海明%邓运明
李華南%吳謀建%劉峰%顧兵%張海明%鄧運明
리화남%오모건%류봉%고병%장해명%산운명
痛风清消颗粒%急性痛风性关节炎%湿热蕴结%临床研究
痛風清消顆粒%急性痛風性關節炎%濕熱蘊結%臨床研究
통풍청소과립%급성통풍성관절염%습열온결%림상연구
Tongfengqingxiao Granules%Acute Gouty Arthritis%damp-heat accumulation type%clinical research
目的:观察痛风清消颗粒治疗湿热蕴结型急性痛风性关节炎的临床疗效和安全性。方法80例湿热蕴结型急性痛风性关节炎患者随机分为治疗组和对照组,每组40例。治疗组口服痛风清消颗粒10g,每日两次;对照组口服双氯芬酸钠片75mg,每日两次。10天为1个疗程,共2个疗程。治疗前后分别进行中医症状积分评定。实验室观察指标包括WBC、 BUA、 ESR、 hs-CRP、 BUN、 Scr、 ALT等,并记录发生的不良反应。结果两组治疗后组间统计学比较差别有显著性意义(P<0.05),组内比较WBC、 BUA、 ESR、 hs-CRP提示差别有极显著性意义(P <0.01)。两组治疗前后安全性评估ALT、 Scr、 BUN差别无显著性意义(P>0.05),中医症状评定治疗组总有效率(97.5%)优于对照组(82.5%),差别有显著性意义(P<0.05),而治疗组不良反应率更低。结论痛风清消颗粒治疗湿热蕴结型急性痛风性关节炎效果良好且安全性高,值得临床推广。
目的:觀察痛風清消顆粒治療濕熱蘊結型急性痛風性關節炎的臨床療效和安全性。方法80例濕熱蘊結型急性痛風性關節炎患者隨機分為治療組和對照組,每組40例。治療組口服痛風清消顆粒10g,每日兩次;對照組口服雙氯芬痠鈉片75mg,每日兩次。10天為1箇療程,共2箇療程。治療前後分彆進行中醫癥狀積分評定。實驗室觀察指標包括WBC、 BUA、 ESR、 hs-CRP、 BUN、 Scr、 ALT等,併記錄髮生的不良反應。結果兩組治療後組間統計學比較差彆有顯著性意義(P<0.05),組內比較WBC、 BUA、 ESR、 hs-CRP提示差彆有極顯著性意義(P <0.01)。兩組治療前後安全性評估ALT、 Scr、 BUN差彆無顯著性意義(P>0.05),中醫癥狀評定治療組總有效率(97.5%)優于對照組(82.5%),差彆有顯著性意義(P<0.05),而治療組不良反應率更低。結論痛風清消顆粒治療濕熱蘊結型急性痛風性關節炎效果良好且安全性高,值得臨床推廣。
목적:관찰통풍청소과립치료습열온결형급성통풍성관절염적림상료효화안전성。방법80례습열온결형급성통풍성관절염환자수궤분위치료조화대조조,매조40례。치료조구복통풍청소과립10g,매일량차;대조조구복쌍록분산납편75mg,매일량차。10천위1개료정,공2개료정。치료전후분별진행중의증상적분평정。실험실관찰지표포괄WBC、 BUA、 ESR、 hs-CRP、 BUN、 Scr、 ALT등,병기록발생적불량반응。결과량조치료후조간통계학비교차별유현저성의의(P<0.05),조내비교WBC、 BUA、 ESR、 hs-CRP제시차별유겁현저성의의(P <0.01)。량조치료전후안전성평고ALT、 Scr、 BUN차별무현저성의의(P>0.05),중의증상평정치료조총유효솔(97.5%)우우대조조(82.5%),차별유현저성의의(P<0.05),이치료조불량반응솔경저。결론통풍청소과립치료습열온결형급성통풍성관절염효과량호차안전성고,치득림상추엄。
Objectives To observe the clinical efficacy and safety of Tongfengqingxiao granules on damp-heat accumulation type of acute gouty arthritis (AGA) . Methods 80 patients of damp-heat accumulation type of AGA were randomly divided into two groups, 40 pa-tients in each group. The treatment group was oral y taken with Tongfengqingxiao granules;10g twice a day while the control group was treated with Diclofenac sodium sustained released tablet, 75mg twice a day. 10 day for a course and total y two courses. The TCM symp-tom assessments were compared before and after treatment respectively. The laboratory indexes such as WBC, BUA, ESR, hs-CRP, BUN, Scr, ALT were observed. Adverse reactions were recorded daily. Results There were significant differences between two groups in WBC, BUA, ESR, hs-CRP after the treatment ( P <0.05) . Both groups had very significant differences in WBC, BUA, ESR, hs-CRP after treatment (P <0.01) . The safety evaluation indexes such as the ALT, Scr, BUN had no significant differences between two groups before and after treatment ( P <0.05) . The TCM symptom assessments of two groups had significant differences ( P<0.05) while the treatment group had lower adverse effects. Conclusions The Tongfengqingxiao Granules had good curative effect and safety in AGA with damp-heat accumulation. It is worthy of clinical promotion.